User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

1752

Interactions with Platform & by Email *

INTERACTIONS

315

Unique # Participated *

PARTICIPANTS

70

Responses Validated *

VALIDATIONS

16

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Outlook for Global Biobanking Industry.....II-4
Global Biobanking Trends.....II-4
Pharma and Biotech Companies Increasingly Outsource Biobanking.....II-4
1$100
   Research-based Biobanks Continue to Dominate Industry.....II-5
Umbrella Organizations Initiated for Coordinating Research Biobanks.....II-5
1$100
   Advanced Technology Employed for Sample Storage.....II-6
Potential for Expansion of Commercial Biobanks in Tissue Banking Market.....II-6
Ethical and Legal Issues Concerning Biobanking.....II-6
2$125
   Challenges Confronting Global Biobanking.....II-84$175
   Stem Cell Banking – An Outlook.....II-12
Key Players in Stem Cell Banking Market.....II-12
Table 1: Global Market for Stem Cell Banking (2010): Percentage Share Breakdown by Major Players - ViaCell, Cryo-Cell, Osiris Therapeutics, Geron Corporation, Cytori Therapeutics, International Stem Cell Corporation, Arthersys and Others (includes corresponding Graph/Chart).....II-12
1$350
   Service Overview.....II-13
Introduction to Stem Cells.....II-13
Types of Stem Cells Banked.....II-13
Haematopoietic Stem Cells (HSC).....II-13
Mesenchymal Stem Cells (MSC).....II-13
1$100
   Current State of Cord Blood Banking Market.....II-14
Major Cord Blood Banking Trends.....II-14
Charges of Services and Products Vary Across Markets.....II-14
Cord Blood Biobanks Adopt New Storage Technologies.....II-14
1$100
   Ethical and Legal Aspects of Cord Blood Markets.....II-15
Regional Overview.....II-15
The United States.....II-15
1$100
   Europe.....II-16
Asia-Pacific.....II-16
Latin America.....II-16
Cord Blood Versus Bone Marrow Stem Cells.....II-16
Advantages of Cord Blood over Bone Marrow in Transplantation.....II-16
Ease of Procurement of Cord Blood Stem Cells.....II-16
1$100
   Disadvantages of Cord Blood Stem Cells Over Bone Marrow.....II-17
Private Cord Blood Banks Versus Public Banks.....II-17
1$100
   Regulation and Quality Assurance.....II-18
Ownership of Donated Sample.....II-18
Commercialization and Patenting.....II-18
Opportunities and Threats Facing Cord Blood Banking.....II-18
3$300
   Service Overview.....II-21
Introduction to Cord Blood Banking.....II-21
Applications of Cord Blood Banking in Treatment of Diseases.....II-21
Advantages of Cord Blood Banking Over Embryonic Stem Cell Banking.....II-21
Private and Public Cord Blood Banks.....II-21
1$350
   Table 2: Worldwide Distribution of Private Cord Blood Banks (2010): Breakdown by Leading Geographic Regions Ranked by Number of Operating Private Banks (includes corresponding Graph/Chart).....II-222$200
   Introduction to Biobanking.....II-24
Various Biobanking Processes.....II-24
Classification of Biobanks.....II-24
2$200
   Classification of Human Biobanks Based on Various Factors.....II-26
Various Functions of Biobanks.....II-26
1$100
   Applications of Biobanks in Diverse Fields of Study.....II-27
Biobanking Equipment and Automation Systems.....II-27
1$100
   Major Types of Biobanking Equipment.....II-28
Ultra Low Temperature Freezer.....II-28
Automated Liquid Handling Systems.....II-28
1$100
   Laboratory Information Management Systems.....II-291$100
   Tran-Scell Biologics to Initiate Stem Cell Bank in Hyderabad.....II-30
ViaCord Introduces Umbilical Cord Tissue Stem Cells Storage.....II-30
WHEATON Launches KeepIT Freezer Box for Biobanking.....II-30
1$100
   Provia Laboratories Introduces Proviasette™ Biosample Storage Cassettes.....II-31
Bluechiip and STMicroelectronics to Introduce Tracking Tags.....II-31
1$100
   RainDance to Introduce DeepSeqTM FFPE Solution for Discovering Rare Cancer
  Mutations.....II-32
Desmon Expands Range of Ultra Low Temperature Freezers for Biobanks.....II-32
Exiqon Launches GLP Compliant Services for miRNA Biomarker Screening.....II-32
1$100
   Cryo-Cell International to Introduce Cryology RTS® Reproductive Tissue Storage
  Service.....II-33
NGC Medical and Bio Serve Establish BioServe-Europe.....II-33
1$100
   Covance Opens Advanced Biorepository Facility.....II-34
Vanderbilt University Opens DNA Biobank.....II-34
Estonian Genome Center to Open Biorepository.....II-34
Biomatrica Introduces Biomatrica Connect™.....II-34
1$100
   Thermo Fisher Scientific Introduces Biospecimen and Biobanking Management Software
  Solution.....II-35
Aurora Opens Robotic Biorepository and Informatics Technology Databank.....II-35
1$100
   LABVANTAGE Launches 90 Day at US$ 90,000 Biobanking Solution.....II-361$100
   Cord Blood America Acquires UCB Samples and Laboratory Equipment from RGI.....II-37
Cord Blood America Inks Supply Agreement with Tissue and Cell Bank.....II-37
Cord Blood America Acquires Minority Stake in Stem Cells VIDAPLUS.....II-37
Kaiser Permanente Center to Begin US$100,000 Specimen Collection at NW Biobank.....II-37
1$100
   Finland Invests in Biomedinfra to Develop Biobanking, Bioinformatics, Biomedical
  Infrastructure.....II-38
ViaCord Unveils New Umbilical Cord Blood Stem Cell Unit.....II-38
ViaCord would continue to increase awareness regarding cord blood banking
  importance.....II-38
Tissue Solutions Gains Approval for Ethical Biobanking of Psoriasis Skin
  Samples.....II-38
1$100
   Integrated BioBank of Luxembourg Inks Agreement with WaferGen Biosystems.....II-39
LifeTechnologies Signs Strategic Partnership Agreement with IBBL.....II-39
1$100
   Air Liquide Healthcare Acquires Pacific Science.....II-40
Cogenics Collaborates with SinoGenoMax for Clinical Genotyping in China.....II-40
Novo Nordisk Foundation to Establish Danish Biobank.....II-40
EU to Offer Cross-Border Tax Breaks for Biobanking.....II-40
Gentel Biosciences to Provide Assays for SCOPE Study’s Pregnancy Biobank.....II-40
1$100
   CordLife Announces Plans for Expanding Operations in India, China.....II-41
deCODE Genetics Divests Islensk Erfdagreining to Saga Investments LLC.....II-41
Cord Blood Bank, Cryo-Save Forays Into Indian Market.....II-41
1$100
   HUNT Biobank to Deploy Thermo Fisher Scientific’s LIMS for Norway Health
  Studies.....II-42
HIV Vaccine Trials Network to Deploy BARC’s Biobanking in South Africa.....II-42
1$100
   Biobank Service Providers.....II-43
Asterand PLC (US).....II-43
CBR Systems, Inc (US).....II-43
Cord Blood America, Inc. (US).....II-43
Cryo-Cell International, Inc. (US).....II-43
1$100
   Cryo-Save Group NV (The Netherlands).....II-44
LifebankUSA (US).....II-44
Tissue Solutions Ltd (UK).....II-44
1$100
   ViaCord (US).....II-45
Vita 34 AG (Germany).....II-45
Biobank Resources & Equipment Suppliers/ Manufacturers.....II-45
BioKryo GmbH (Germany).....II-45
GenVault (US).....II-45
Hamilton Storage Technologies (US).....II-45
1$100
   LABVANTAGE Solutions, Inc. (US).....II-46
NEXUS Biosystems (US).....II-46
REMP AG (Switzerland).....II-46
Qiagen NV (The Netherlands).....II-46
1$100
   TAP Biosystems (UK).....II-47
ThemoGenesis (US).....II-47
Thermo Scientific (US).....II-47
1$100
   Table 3: World Recent Past, Current and Future Analysis for Biobank Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-481$350
   Table 4: World Historic Review for Biobank Services Market Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-491$350
   A. Market Analysis.....II-50
Outlook.....II-50
Biobanking in the US – Ethical and Legal Aspects.....II-50
US Pioneering the Global Cord Blood Banking Market.....II-50
Research-based Biobanks in the US.....II-50
2$125
   Product/Service Introductions.....II-525$225
   Recent Industry Activity.....II-572$125
   Key Players.....II-594$175
   B. Market Analytics.....II-63
Table 5: US Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-63
1$350
   Table 6: US Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-641$350
   A. Market Analysis.....II-65
Outlook.....II-65
EU to Offer Cross-Border Tax Breaks for Biobanking.....II-65
Overview of European Research-based Biobanking.....II-65
Ownership of Research-based Biobanks.....II-65
1$100
   Table 7: European Research-based Biobanks (2010): Percentage Share Breakdown by Biobank Ownership Types - National or Regional Agencies, Universities, Non-profit Organizations and Private Organizations (includes corresponding Graph/Chart).....II-66
Purpose and Scale of Operations.....II-66
Table 8: European Research-based Biobanks (2010): Percentage Breakdown by Major Purpose Types (includes corresponding Graph/Chart).....II-66
1$350
   Table 9: European Research-based Biobanks (2010): Percentage Breakdown by Major Research Formats - Public Research, Public and Clinical Research, Clinical Research, Multiple Format Research and Others (includes corresponding Graph/Chart).....II-67

Table 10: Research-based Biobanks in Europe (2010): Percentage Breakdown of Biobank Categories Based on Scale of Operation (includes corresponding Graph/Chart).....II-67
1$350
   Data and Sample Collection.....II-68
Ethics and Sharing of Biosamples.....II-68
Legal Aspects.....II-68
1$100
   B. Market Analytics.....II-69
Table 11: European Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-69
1$350
   Table 12: European Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-701$350
   A. Market Analysis.....II-71
Outlook.....II-71
Research-based Biobanks.....II-71
1$100
   B. Market Analytics.....II-72
Table 13: French Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-72
1$350
   Table 14: French Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-731$350
   A. Market Analysis.....II-74
Outlook.....II-74
Research-based Biobanks in Germany.....II-74
Overview of Biobank Structure in Germany – Major Research Biobanks,
  Hospital-Affiliated Biobanks and Private Cord Blood Banks.....II-74
1$100
   Key Players.....II-75
B. Market Analytics.....II-75
Table 15: German Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-75
1$350
   Table 16: German Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-761$350
   A. Market Analysis.....II-77
Outlook.....II-77
Research-based Biobanks.....II-77
Product/Service Introductions.....II-77
2$125
   B. Market Analytics.....II-79
Table 17: Italian Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-79
1$350
   Table 18: Italian Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-801$350
   A. Market Analysis.....II-81
Outlook.....II-81
Research-based Biobanks in the UK.....II-81
1$100
   The UK Biobank.....II-82
Product/Service Introduction.....II-82
Key Players.....II-82
1$100
   B. Market Analytics.....II-83
Table 19: UK Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-83
1$350
   Table 20: UK Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-841$350
   A. Market Analysis.....II-85
Outlook.....II-85
Research-based Biobanks.....II-85
1$100
   Key Players.....II-861$100
   B. Market Analytics.....II-87
Table 21: Dutch Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-87
1$350
   Table 22: Dutch Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-881$350
   A. Market Analysis.....II-89
Outlook.....II-89
Research Based Biobanks - Focus on Select Regions.....II-89
Sweden.....II-89
1$100
   Norway.....II-90
Denmark.....II-90
1$100
   Finland.....II-911$100
   Iceland.....II-92
deCODE Genetics.....II-92
1$100
   Estonia.....II-93
Estonian Genome Project.....II-93
Product/Service Introductions.....II-93
1$100
   Recent Industry Activity.....II-942$125
   Key Player.....II-961$100
   B. Market Analytics.....II-97
Table 23: Rest of Europe Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-97
1$350
   Table 24: Rest of Europe Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-981$350
   A. Market Analysis.....II-99
Outlook.....II-99
Research-Based Biobanks - Focus on Select Regional Markets.....II-99
Canada.....II-99
1$100
   Asia-Pacific.....II-100
Japan.....II-100
China.....II-100
Chinese Cord Blood Banking Markets Offer High Growth Potential.....II-100
1$100
   India.....II-101
Cord Blood Banking in India Poised for a Significant Growth.....II-101
Enhanced Cord Blood Banking Fuels Medical Tourism in India.....II-101
1$100
   Singapore.....II-102
Australia.....II-102
Taiwan.....II-102
1$100
   South Korea.....II-103
Latin America.....II-103
Mexico.....II-103
Service/Product Introduction.....II-103
1$100
   Recent Industry Activity.....II-1041$100
   Key Player.....II-1051$100
   B. Market Analytics.....II-106
Table 25: Rest of World Recent Past, Current & Future Analysis for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-106
1$350
   Table 26: Rest of World Historic Review for Biobanking Services Independently Analyzed with Annual Revenues in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1071$350
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com